Published in J Clin Invest on September 01, 1991
Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein plasma levels. J Lipid Res (2009) 0.94
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest (1993) 0.93
Exercise and dietary-mediated reductions in postprandial lipemia. J Nutr Metab (2014) 0.80
Assessment of French patients with LPL deficiency for French Canadian mutations. J Med Genet (1997) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Direct cloning and sequence analysis of enzymatically amplified genomic sequences. Science (1986) 19.54
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (1988) 13.54
Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sci U S A (1981) 12.86
Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol (1985) 11.53
Human lipoprotein lipase complementary DNA sequence. Science (1987) 9.50
A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res (1976) 4.38
Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci U S A (1989) 3.26
The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature (1989) 2.75
Carbohydrate-induced and fat-induced lipemia. Trans Assoc Am Physicians (1961) 2.45
Transport and storage of vitamin A. Science (1990) 2.39
Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest (1960) 2.32
Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. J Biol Chem (1982) 1.80
TISSUE DISTRIBUTION AND METABOLISM OF NEWLY ABSORBED VITAMIN A IN THE RAT. J Lipid Res (1965) 1.80
Structure of the human lipoprotein lipase gene. Biochemistry (1989) 1.72
LIPOLYTIC ACTIVITY OF POST-HEPARIN PLASMA IN HYPERGLYCERIDEMIA. J Lipid Res (1963) 1.66
Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest (1990) 1.58
Missense mutation (Gly----Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem (1990) 1.57
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest (1987) 1.45
Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits. J Lipid Res (1977) 1.40
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest (1982) 1.39
Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest (1973) 1.38
Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci U S A (1984) 1.36
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest (1987) 1.33
Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency. Am J Hum Genet (1990) 1.31
Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest (1986) 1.19
Vitamin A metabolism. Fed Proc (1980) 1.19
Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin Chem (1986) 1.19
Two-dimensional electrophoresis of human plasma apolipoproteins. Clin Chem (1984) 1.17
Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects. J Lipid Res (1984) 1.14
Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res (1988) 1.11
Tissue lipoprotein lipase in normal individuals and in individuals with exogenous hypertriglyceridemia and the relationship of this enzyme to assimilation of fat. J Clin Invest (1967) 1.11
Chylomicron clearance in normal and hyperlipidemic man. Metabolism (1976) 1.08
Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. Med Clin North Am (1982) 1.07
Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man. Eur J Clin Invest (1980) 1.06
A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians. N Engl J Med (1991) 1.06
Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism (1990) 1.06
Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey. J Clin Invest (1988) 1.05
Heterogeneity of primary lipoprotein lipase deficiency. Metabolism (1980) 1.05
An enzyme-linked immunoassay for lipoprotein lipase. Anal Biochem (1987) 1.00
Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res (1979) 1.00
Defective enzyme protein in lipoprotein lipase deficiency. Eur J Clin Invest (1989) 0.99
Lipoprotein lipaseBethesda: a single amino acid substitution (Ala-176----Thr) leads to abnormal heparin binding and loss of enzymic activity. Proc Natl Acad Sci U S A (1990) 0.99
Plasma lipoprotein retinoids after vitamin A feeding in normal man: minimal appearance of retinyl esters among low-density lipoproteins. Metabolism (1983) 0.98
Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene. Am J Hum Genet (1990) 0.97
Effects of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest (1985) 0.93
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest (1990) 0.93
Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins. J Clin Invest (1990) 0.89
Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency. Mol Biol Med (1990) 0.89
Compound heterozygote for lipoprotein lipase deficiency: Ser----Thr244 and transition in 3' splice site of intron 2 (AG----AA) in the lipoprotein lipase gene. Am J Hum Genet (1990) 0.89
Exchange of retinyl and cholesteryl esters between lipoproteins of rabbit plasma. Biochim Biophys Acta (1982) 0.88
Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome. J Biol Chem (1991) 0.88
Chylomicron metabolism during dietary-induced hypercholesterolemia in dogs. J Lipid Res (1981) 0.87
Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine. J Lipid Res (1990) 0.81
Diet and HDL metabolism: high carbohydrate vs. high fat diets. Adv Exp Med Biol (1987) 0.81
Lack of secretion of retinyl ester by livers of normal and cholesterol-fed rabbits. J Nutr (1983) 0.78
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet (1993) 9.34
Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA (1990) 6.25
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry (2000) 4.87
Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A (1999) 4.62
The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N Engl J Med (1993) 4.61
Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet (1994) 4.33
Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab (2001) 4.03
Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet (1992) 3.89
Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction. Neuroimage (2002) 3.58
The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med (1998) 3.13
Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1992) 2.82
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc (2000) 2.80
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med (1993) 2.65
Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med (1997) 2.50
Development of a rapid assimilable organic carbon method for water. Appl Environ Microbiol (1993) 2.45
Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med (1989) 2.43
Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA (1992) 2.42
THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet (1993) 2.37
The accuracy of self-report of fractures in elderly women: evidence from a prospective study. Am J Epidemiol (1992) 2.33
Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry (1986) 2.33
Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol (1996) 2.09
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day. Am J Cardiol (1997) 1.98
Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med (1998) 1.96
A midline dissociation between error-processing and response-conflict monitoring. Neuroimage (2003) 1.94
Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene. Genes Dev (1989) 1.93
The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol (1988) 1.93
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation (2000) 1.85
Cloning of cDNA sequences of human adenosine deaminase. Proc Natl Acad Sci U S A (1983) 1.81
Changes in needle sharing behavior among intravenous drug users: San Francisco, 1986-88. Am J Public Health (1990) 1.80
Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res (1995) 1.77
Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1986) 1.70
Cocaine administration decreases functional connectivity in human primary visual and motor cortex as detected by functional MRI. Magn Reson Med (2000) 1.69
Age-related decrements in bone mineral density in women over 65. J Bone Miner Res (1992) 1.69
Cell type-specific transcriptional regulation of the human adenosine deaminase gene. Nucleic Acids Res (1989) 1.63
Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing. Proc Natl Acad Sci U S A (1987) 1.61
Amygdala response to both positively and negatively valenced stimuli. Neuroreport (2001) 1.60
Bacterial biomass, metabolic state, and activity in stream sediments: relation to environmental variables and multiple assay comparisons. Appl Environ Microbiol (1985) 1.60
Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines. Mol Cell Biol (1984) 1.60
Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. Osteoporos Int (1994) 1.60
Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab (2010) 1.60
Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia. Atherosclerosis (2000) 1.58
Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem (1989) 1.58
Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. J Clin Endocrinol Metab (2013) 1.57
Kyphosis in older women and its relation to back pain, disability and osteopenia: the study of osteoporotic fractures. Osteoporos Int (1994) 1.52
Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med (2001) 1.51
Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol (1990) 1.49
Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. Arch Intern Med (2000) 1.47
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Arch Intern Med (1994) 1.46
Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am J Cardiol (2000) 1.45
The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene (2001) 1.45
The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia. Anaesthesia (1993) 1.44
Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements. J Clin Invest (1988) 1.44
Amplification of KP elements associated with the repression of hybrid dysgenesis in Drosophila melanogaster. Genetics (1988) 1.41
Correlates of kyphosis in older women. The Fracture Intervention Trial Research Group. J Am Geriatr Soc (1997) 1.40
Updated fracture incidence rates for the US version of FRAX. Osteoporos Int (2009) 1.40
Application of the National Cholesterol Education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Eur Heart J (2000) 1.38
Practice-related functional activation changes in a working memory task. Microsc Res Tech (2000) 1.38
Immunoreactive protein in adenosine deaminase deficient human lymphoblast cell lines. J Biol Chem (1982) 1.37
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin. J Am Coll Cardiol (1998) 1.36
The NM23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with BglII. Genes Chromosomes Cancer (1992) 1.34
Relationship between finger movement rate and functional magnetic resonance signal change in human primary motor cortex. J Cereb Blood Flow Metab (1996) 1.33
Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the study of osteoporotic fractures. Osteoporos Int (2002) 1.32
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA (1996) 1.29
Degenerative change in symptomatic scaphoid nonunion. J Hand Surg Am (1987) 1.28
Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1. Hum Mol Genet (1993) 1.27
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol (2000) 1.27
A human BRCA1 gene knockout. Nature (1995) 1.27
Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Mol Cell Biol (1992) 1.26
Calmodulin-free skeletal-muscle troponin C prepared in the absence of urea. Biochem J (1981) 1.24
Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial. Am J Clin Nutr (1999) 1.22
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. J Womens Health Gend Based Med (2001) 1.22
A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2007) 1.22
Hormonal predictors of bone loss in elderly women: a prospective study. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1998) 1.22
Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis. J Clin Endocrinol Metab (2006) 1.21
Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int (2001) 1.18
Compliance to treatment for hypertension in elderly patients: the SHEP pilot study. Systolic Hypertension in the Elderly Program. J Gerontol (1987) 1.18
Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study. Brain Res (1998) 1.18
Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V. Arterioscler Thromb (1991) 1.17
A generalized equation for prediction of VO2peak from 1-mile run/walk performance. Med Sci Sports Exerc (1995) 1.17
Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol (1990) 1.17
Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene (1998) 1.16
Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene (1999) 1.16
Biomarkers for smoking cessation. Clin Pharmacol Ther (2013) 1.15
Functional MRI of human Pavlovian fear conditioning: patterns of activation as a function of learning. Neuroreport (1999) 1.15
Sequence of human adenosine deaminase cDNA including the coding region and a small intron. Nucleic Acids Res (1984) 1.13
A parametric manipulation of central executive functioning. Cereb Cortex (2000) 1.11
Mapping of semantic, phonological, and orthographic verbal working memory in normal adults with functional magnetic resonance imaging. Neuropsychology (1999) 1.11
Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int J Cancer (1993) 1.10
Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther (1999) 1.09
Dissecting a locus control region: facilitation of enhancer function by extended enhancer-flanking sequences. Mol Cell Biol (1995) 1.08
The intergenic region of maize streak virus contains promoter elements involved in rightward transcription of the viral genome. EMBO J (1988) 1.08
Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem (1990) 1.08